Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $13,600,000 |
Sells | 21 | $16,684,697 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Apr 2024 20:48 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Apr 2024 | Sale | 1,750 | 25.74 | 45,045 | D |
03 Apr 2024 19:18 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 01 Apr 2024 | Sale | 8,153 | 31.78 | 259,102 | D |
29 Mar 2024 16:52 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Mar 2024 | Sale | 5,833 | 35.0438 | 204,410 | D |
20 Mar 2024 16:40 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 18 Mar 2024 | Sale | 1,750 | 31.27 | 54,722 | D |
29 Feb 2024 18:01 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Feb 2024 | Sale | 1,909 | 30 | 57,270 | D |
21 Feb 2024 17:41 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Feb 2024 | Sale | 1,750 | 27.67 | 48,422 | D |
12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,996 | 27.5 | 54,890 | D |
12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 2,916 | 27.5 | 80,190 | D |
12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,332 | 27.5 | 36,630 | D |
12 Feb 2024 20:22 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 08 Feb 2024 | Sale | 92,001 | 27.1282 | 2,495,822 | D |
07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 552 | 30.05 | 16,588 | D |
07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 6,000 | 30.05 | 180,300 | D |
07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 6,000 | 30.05 | 180,300 | D |
07 Feb 2024 20:32 | FDMT | 4D Molecular Therapeutics Inc | KIM ROBERT YOUNG | Chief Medical Officer | 05 Feb 2024 | Sale | 12,000 | 30.05 | 360,600 | D |
25 Jan 2024 16:59 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 23 Jan 2024 | Sale | 5,696 | 18.4079 | 104,851 | D |
08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 05 Jan 2024 | Sale | 133 | 20.105 | 2,674 | D |
08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 04 Jan 2024 | Sale | 40,732 | 20.3084 | 827,202 | D |
08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 05 Jan 2024 | Sale | 28,104 | 19.5632 | 549,804 | D |
08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 18 Dec 2023 | Sale | 4,702 | 18.129 | 85,243 | D |
08 Jan 2024 16:19 | FDMT | 4D Molecular Therapeutics Inc | KIRN DAVID | Chief Executive Officer | 15 Dec 2023 | Sale | 28,632 | 17.2685 | 494,432 | D |
05 Jan 2024 17:44 | FDMT | 4D Molecular Therapeutics Inc | VIKING GLOBAL INVESTORS LP | 10% | 04 Jan 2024 | Sale | 540,000 | 19.53 | 10,546,200 | I |
11 May 2023 17:50 | FDMT | 4D Molecular Therapeutics Inc | VIKING GLOBAL INVESTORS LP | 10% | 09 May 2023 | Purchase | 850,000 | 16 | 13,600,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)